Pro 2013-012 (Jianfeng Group's Announcement on Subsidiary Guarantee)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2013-012
Announcement of Zhejiang Jianfeng Group Co., Ltd.
Providing Guarantee to Holding Subsidiaries
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Tips
● Names of Guarantees: Daye Jianfeng Cement Co., Ltd., Zhejiang Jianfeng Pharmaceutical Co., Ltd., Jinhua Pharmaceutical Co., Ltd., Zhejiang Jianfeng International Trading Co., Ltd., Yunnan Jianfeng Cement Co., Ltd.
● Proposed guarantee amount: set guarantee amount of 0.4 billion yuan.
● Is there any counter-guarantee for this guarantee: No
● Cumulative number of overdue external guarantees: No
Overview of 1. guarantees
On April 19, 2013, Zhejiang Jianfeng Group Co., Ltd. held the 10th meeting of the 8th Board of Directors. Nine directors should be present at the meeting. Independent director Deng Mingran entrusted independent director Liu Jiajian to attend the meeting due to official business. The remaining eight directors attended the meeting in person; they complied with the relevant provisions of the "Company Law" and the "Articles of Association", and the resolutions made were legal and effective. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the "Proposal on Providing Guarantees to Holding Subsidiaries" was reviewed and passed with 9 votes in favor, 0 votes against, and 0 abstentions. Basic information of
2. guarantor
, Zhejiang Jianfeng Pharmaceutical Co., Ltd., with a registered capital of 149.07 million yuan, of which: the company accounts for 99.16, and its registered address is in Jinhua Industrial Park, Zhejiang Province. Its main business is the manufacture, sale and export of eye drops, ear drops, large volume injection, small volume injection and bulk drugs (azithromycin sulfate, L-aspartate amlodipine, paroxidine hydrochloride), freeze-dried powder injection, powder injection (cephalosporins), tablet, hard capsule, granule, ointment, dropping pill, bulk drug , etc. .
2. daye peak cement co., ltd. has a registered capital of 0.25 billion yuan, of which the company accounts for 6% and the company's holding subsidiary Zhejiang peak cement co., ltd. (the company holds 93.91) accounts for 70%. registered address: daye city hubei province security town; main business: cement, cement clinker, cement mechanical and electrical equipment manufacturing and sales; building materials products such as sales.
. Yunnan Jianfeng Cement Co., Ltd. has a registered capital of 0.15 billion yuan, of which: the company accounts for 75%, the holding subsidiary Jianfeng Cement (the company holds 93.91) accounts for 25%, and its registered address is 43 kilometers from Silan Highway, Liushun Township, Simao District, Pu 'er City, Yunnan Province. Its main business is cement production; sales of cement and cement products, building materials, gravel, woven bags, cement grinding; cement export trade.
. Jinhua pharmaceutical co., ltd. has a registered capital of 22 million yuan, of which: Zhejiang Jianfeng pharmaceutical co., ltd., the controlling subsidiary of the company, accounts for 90%, the company accounts for 10%, and its registered address is 1180 huancheng east road, Jinhua city; Main business: Main business: licensed business items: drug business (for details, please refer to the validity period of the drug business license until December 1, 2014). Prepackaged food (the license is valid until March 9, 2014), hazardous chemicals (see the license for the specific business scope, and the license is valid until January 16, 2014), medical devices (see the license for the specific business scope, and the license is valid until September 14, 2015), etc. The drug business license mainly includes: sales of Chinese patent medicines, Chinese medicinal materials, Chinese medicinal tablets, chemical preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, etc. .
, Zhejiang Jianfeng International Trade Co., Ltd., with a registered capital of 30 million yuan, of which: 93.33 of our company and 6.67 of Jianfeng Pharmaceutical Co., Ltd., registered address: 88 changchun West Road, Jindong Economic Development Zone, Zhejiang Province, mainly engaged in self-management and agency of import and export of various commodities and technologies, engaged in processing of imported materials and "three to one supplement" business; To carry out countertrade and re-export trade, warehousing of bonded goods and general goods (except dangerous goods), pharmaceutical intermediates, pharmaceutical equipment , etc. .
Key audited 2012 financial data of the above subsidiaries (in: ten thousand yuan)
company name |
total assets |
asset-liability ratio% |
total operating income |
net profit |
Daye Jianfeng Cement Co., Ltd. |
70574.18 |
50.79 |
57132.60 |
7626.51 |
Zhejiang Jianfeng Pharmaceutical Co., Ltd. |
60276.03 |
54.17 |
83108.99 |
2742.57 |
Jinhua Pharmaceutical Co., Ltd. |
25088.14 |
73.04 |
60084.02 |
371.03 |
Yunnan Jianfeng Cement Co., Ltd. |
50685.15 |
74.36 |
5960.33 |
-1411.81 |
Zhejiang Jianfeng International Trade Co., Ltd. |
7949.65 |
77.98 |
15087.30 |
-255.23 |
3. The main content of the guarantee
1, to guarantee the controlling subsidiary's borrowing from financial institutions, set the following limits:
Guaranteed Unit |
Set Guarantee Limit (RMB 10,000) |
daye peak Cement Co., Ltd. |
10000 |
zhejiang Jianfeng Pharmaceutical Co., Ltd. |
10000 |
Jinhua Pharmaceutical Co., Ltd. |
10000 |
Zhejiang Jianfeng International Trading Co., Ltd. |
5000 |
Yunnan Jianfeng Cement Co., Ltd. |
5000 |
Total |
40000 |
2, Agree to provide guarantee letter for 337 Zhejiang Jianfeng International Trade Co., Ltd, provide corresponding guarantee for the goods stored in the company by the customers of Zhejiang Jianfeng International Trade Co., Ltd.
The guarantee within the above amount is authorized to be executed by the chairman of the board of directors.
above matters shall be submitted to the shareholders' meeting for deliberation.
4. the opinion of the board of directors
The above guaranteed companies are all controlling subsidiaries of the company. The company can effectively control the guarantee risks, and the board of directors agrees to the above guarantees. The three independent directors of the company issued an independent opinion that was expressly agreed.
5. Cumulative Number of External Guarantees and Number of Overdue Guarantees
As of the disclosure date of this announcement, the total amount of external guarantees approved by the company and its controlling subsidiaries is 670 million yuan, accounting for 44.22 of the total owner's equity attributable to the parent company in 2012. The total amount of guarantee approved by the company to the holding subsidiary is 730 million yuan, accounting for 48.18 of the total owner's equity attributable to the parent company in 2012.
As of the disclosure date of this announcement, the actual balance of external guarantees of the company and its controlling subsidiaries was 70 million yuan, accounting for 4.62 of the total owner's equity attributable to the parent company by the audited consolidated caliber in 2012; The actual balance of the company's guarantee to the holding subsidiary is 206.37 million yuan, accounting for 13.62 of the total owner's equity attributable to the parent company by the audited consolidated caliber in 2012.
6. Reference Document Catalogue
1 , Resolution of the Tenth Meeting of the Eighth Board of Directors of the Company;
2 , copy of the business license of the guarantor;
hereby announces
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 23, 2013
More information
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-30
Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise
Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has
2020
07-31
Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute
A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody
2020
07-31
On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.
2020
07-31
Peak natural products pollution control results by the industry attention
As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.
2020
07-31